Johnson & Johnson (JNJ) EMA's CHMP adopted positive opinion recommending change to terms of marketing authorisation for Rezolsta

#JOHNSON & JOHNSON#JNJ.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#JNJ#US EQUITIES
Published: Updated: